Spruce Biosciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRB and other ETFs, options, and stocks.

About SPRB

Spruce Biosciences, Inc operates as a late-stage biopharmaceutical company, which focuses on the development of novel therapies for rare diseases affecting the endocrine system. The firm is initially developing its wholly-owned product candidate, tildacerfont, as the non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia. 

CEO
Javier Szwarcberg
CEOJavier Szwarcberg
Employees
15
Employees15
Headquarters
Daly City, California
HeadquartersDaly City, California
Founded
2014
Founded2014
Employees
15
Employees15

SPRB Key Statistics

Market cap
33.10M
Market cap33.10M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
25.31K
Average volume25.31K
High today
$1.50
High today$1.50
Low today
$1.40
Low today$1.40
Open price
$1.43
Open price$1.43
Volume
14.51K
Volume14.51K
52 Week high
$5.98
52 Week high$5.98
52 Week low
$1.16
52 Week low$1.16

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

SPRB Earnings

-$0.66
-$0.44
-$0.22
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.